ResMed tends to opt for strategic buyouts to boost SaaS revenues. As of the fiscal fourth-quarter end, the SaaS business reflected strong contributions from the MEDIFOX DAN brand in Germany and growth ...

Bank of America Securities analyst Lyanne Harrison has reiterated their bullish stance on RMD stock, giving a Buy rating on October 10. Lyanne ...

ResMed stock has been rallying—and the best move now is simply to hold on for more gains. Back in July, ResMed stock fell 7% after Ely Lilly released data showing that one of its GLP-1 obesity ...

After hours: October 18 at 5:16 PM EDT Loading Chart for RMD ...

The Resmed CDI (ASX:RMD) share price is up 38.6% since the start of 2024. It's probably worth asking, 'is the RMD share price ...

Ellerston Capital portfolio manager Chris Kourtis plans to tip one of the “most hated” stocks in Australia when he presents ...

Sanctuary Advisors LLC purchased a new position in shares of ResMed Inc. (NYSE:RMD – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The ...

Many analysts see GLP-1 drugs, which have shown positive results in treating sleep apnea, as a threat to CPAP companies. But ResMed, which makes sleep apnea devices, sees an opportunity.

The MyAir consumer app. [Image courtesy of ResMed] ResMed (NYSE: RMD) + today announced new patient-centric products designed to enhance therapy for sleep apnea patients. The new innovations from ...

SAN DIEGO – ResMed unveiled its 2030 strategy to drive growth, profitability and shareholder returns, including investing 7% in R&D, at an Investor Day in New York City. The company also announced its ...